Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: al who wrote (11220)	7/11/1998 10:29:00 AM
From: VLAD	Read Replies (2) \| Respond to of 23519

al, Seems like the AP is the only newswire service that is willing to let the public know about a rat when they smell one. That article talks about the FDA being pressured to fast track approval of drugs while the sick who can be helped are dying. I never knew of a man dying from impotence and being that other ED treatments were already available, fast track approval of Viagra certainly seems strange to me. The more doctors I speak to about the deaths linked to Viagra the more I hear them complaining about money taking president over safety. Shame on the FDA for fast tracking a systemic drug for fast track approval and double shame on them for lying about the dangers of Viagra. I think the FDA will soon see a shake up similar to the type the IRS is experiencing. This entire Viagra fiasco is probably the worst safety blunder of the FDA in the 1990's.